Red Blood Cells Activate Innate Immune System
Red Blood Cells Activate Innate Immune System
Researchers link the ability of the cells to bind and present DNA from pathogens and cell death to anemia, which is common in COVID-19, and immune activation.
Red Blood Cells Activate Innate Immune System
Red Blood Cells Activate Innate Immune System

Researchers link the ability of the cells to bind and present DNA from pathogens and cell death to anemia, which is common in COVID-19, and immune activation.

Researchers link the ability of the cells to bind and present DNA from pathogens and cell death to anemia, which is common in COVID-19, and immune activation.

COVID-19
Sex of Fetus Affects Immune Response to COVID-19 During Pregnancy
Sex of Fetus Affects Immune Response to COVID-19 During Pregnancy
Amanda Heidt | Oct 20, 2021
Male placentas produce more proinflammatory molecules than female placentas, while people carrying male fetuses produce fewer antibodies in response to infection, a study finds.
Shrinking Quarantine
Shrinking Quarantine
Rachael Moeller Gorman | Oct 15, 2021
The CDC now suggests that only children who were within 3 feet, not 6 feet, of an infected student should quarantine, provided they were masked in a classroom. Does the science support this change?
Moderna Vaccine Paused for Young People in Two European Countries
Moderna Vaccine Paused for Young People in Two European Countries
Chloe Tenn | Oct 6, 2021
Health authorities in both countries announced that people under certain age cutoffs are now ineligible for the Spikevax COVID-19 shot due to its association with heart inflammation.
Antiviral Pill Lowers Risks of COVID-19 Hospitalization, Death
Antiviral Pill Lowers Risks of COVID-19 Hospitalization, Death
Chloe Tenn | Oct 1, 2021
Merck reports that its antiviral molnupiravir was effective against early stages of COVID-19 in high-risk patients in a Phase 3 clinical trial.
Our Aching Brains
Our Aching Brains
Bob Grant | Oct 1, 2021
COVID-19 has killed more than 4 million people around the globe and has sickened many millions more. The neurological toll on those of us continuing to live through the pandemic may stretch years or decades into the uncertain future.
WHO Restarts Investigation of COVID-19 Emergence with New Panel
WHO Restarts Investigation of COVID-19 Emergence with New Panel
Chloe Tenn | Sep 28, 2021
A new, more diverse group of researchers is being appointed take over the stalled investigation.
When the Immune Response Makes COVID-19 Worse
When the Immune Response Makes COVID-19 Worse
Alejandra Manjarrez | Sep 27, 2021
If the immune system makes mistakes—reacting late or getting the target wrong—it can amplify the damage wrought by SARS-CoV-2.
Moderna vs. Pfizer: Is There a “Best” mRNA Vaccine?
Moderna vs. Pfizer: Is There a “Best” mRNA Vaccine?
Alejandra Manjarrez | Sep 24, 2021
Both of the mRNA vaccines available in the US are highly effective against severe COVID-19, but recent studies suggest that Moderna’s elicits a stronger immune response and might be better at preventing breakthrough infections.  
Opinion: Scientists Must Combat Scientific Dogmatism
Opinion: Scientists Must Combat Scientific Dogmatism
Ahmed Alkhateeb | Sep 23, 2021
Correcting misinformation and providing reliable data are collective responsibilities of the research community.
Book Excerpt from <em>You Bet Your Life</em>
Book Excerpt from You Bet Your Life
Paul A. Offit | Sep 21, 2021
In his book’s Introduction, physician-scientist Paul A. Offit reviews the unusual constellation of circumstances around the development of COVID-19 vaccines.
Updated Oct 15
To Booster or Not: Scientists and Regulators Debate
To Booster or Not: Scientists and Regulators Debate
Jef Akst | Sep 16, 2021
President Biden’s planned rollout of additional COVID-19 vaccine doses is set to begin next week, but questions remain about who should get them.
NIH Grants $470 Million for Study of Long COVID
NIH Grants $470 Million for Study of Long COVID
Lisa Winter | Sep 16, 2021
The study aims to recruit 40,000 adults and children to get a better sense of the condition that can last weeks or months after infection.
A Surge in Pandemic Research Shines a Spotlight on Preprints
A Surge in Pandemic Research Shines a Spotlight on Preprints
Diana Kwon | Sep 10, 2021
Many scientists have turned to preprints to rapidly disseminate their research on COVID-19, but some disagree with this approach.